| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells
|
Brantley, Eileen
|
|
2005
|
58 |
1 |
p. 62-72
|
article
|
| 2 |
Bortezomib interactions with chemotherapy agents in acute leukemia in vitro
|
Horton, Terzah M.
|
|
2005
|
58 |
1 |
p. 13-23
|
article
|
| 3 |
Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo
|
Guo, Chun-Bao
|
|
2005
|
58 |
1 |
p. 40-49
|
article
|
| 4 |
CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas
|
Kim, Jong Gwang
|
|
2005
|
58 |
1 |
p. 35-39
|
article
|
| 5 |
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme
|
Schott, Anne F.
|
|
2005
|
58 |
1 |
p. 129-135
|
article
|
| 6 |
Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein
|
Pan, Qiangrong
|
|
2005
|
58 |
1 |
p. 99-106
|
article
|
| 7 |
Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo
|
Tao, Lei
|
|
2005
|
58 |
1 |
p. 24-34
|
article
|
| 8 |
Enforced expression of cytosolic 5′-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection
|
Gray, Tasha
|
|
2005
|
58 |
1 |
p. 117-128
|
article
|
| 9 |
5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice
|
Saif, Muhammad Wasif
|
|
2005
|
58 |
1 |
p. 136-142
|
article
|
| 10 |
Human breast cell lines exhibit functional α2-adrenoceptors
|
Vázquez, Stella Maris
|
|
2005
|
58 |
1 |
p. 50-61
|
article
|
| 11 |
Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatment
|
Hooijberg, J. H.
|
|
2005
|
58 |
1 |
p. 1-12
|
article
|
| 12 |
Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization
|
Rose, William C.
|
|
2005
|
58 |
1 |
p. 73-85
|
article
|
| 13 |
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors
|
Eder, Joseph P.
|
|
2005
|
58 |
1 |
p. 107-116
|
article
|
| 14 |
Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer
|
Mori, Kiyoshi
|
|
2006
|
58 |
1 |
p. 86-90
|
article
|
| 15 |
p53 Status does not affect photodynamic cell killing induced by hypericin
|
Lee, H. B.
|
|
2005
|
58 |
1 |
p. 91-98
|
article
|
Journal description